Arabinosylated lipoarabinomannan modulates the impaired cell mediated immune response in Mycobacterium tuberculosis H37Rv infected C57BL/6 mice

Microbes and Infection

Volumn 10, Issue 4, 2008, Pages 349-357

  Majumder, Nivedita ^a   Bhattacharjee, Surajit ^a   Dey, Ranadhir ^a   Pal, Nishith K ^b  

^a Majumdar), Suchandra   (India)

^b CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Antigen presentation; Cellular immunity; Tuberculosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLYCOLIPID; LIPOARABINOMANNAN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CELL SECRETION; CELL WALL; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; INFECTION CONTROL; LUNG ALVEOLUS MACROPHAGE; MOUSE; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SPLEEN CELL; TH1 CELL; TUBERCULOSIS;

ANIMALS; CELL PROLIFERATION; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, CELLULAR; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TH1 CELLS; TUBERCULOSIS;

ARA; BACILLI (CLASS); MUS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 42649084297     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.12.013     Document Type: Article

References (30)

1. Dye C., Scheele S., Dolin P., Pathania V., and Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance Monitoring Project. J. Am. Med. Assoc. 282 (1999) 677-686
2. Clemens D.L., and Horwitz M.A. The Mycobacterium tuberculosis phagosome interacts with early endosome and is accessible to exogenously administered transferring. J. Exp. Med. 184 (1996) 1349-1355
3. Flynn J.L., and Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19 (2001) 93-129
4. Comstock G.W. Epidemiology of tuberculosis. Am. Rev. Respir. Dis. 125 (1982) 8-15
5. Silva C.L., and Lowrie D.B. Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infect. Immun. 68 (2000) 3269-3274
6. Noss E.H., Harding C.V., and Boom W.H. Mycobacterium tuberculosis inhibits MHC Class II antigen processing in murine bone marrow macrophages. Cell. Immunol. 201 (2000) 63-74
7. Dascher C.C., Hiromatsu K., Xiong X., Morehouse C., Watts G., Liu G., McMurray D.N., LeClair K.P., Porcelli S.A., and Brenner M.B. Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int. Immunol. 15 (2003) 915-925
8. Hamasur B., Haile M., and Pawlowski A. Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis. Vaccine 21 (2003) 4081-4093
9. Reddi P.P., Amin A.G., Khandekar P.S., and Talwar G.P. Molecular definition of unique species status of Mycobacterium w; a candidate leprosy vaccine strain. Int. J. Lepr. Other Mycobact. Dis. 62 (1994) 229-236
10. Sur P.K., and Dastidar A.G. Role of Mycobacterium w as adjuvant treatment of lung cancer (non-small cell lung cancer). J. Ind. Med. Assoc. 101 (2003) 118-120
11. Kharkar R. Immune recovery in HIV with Mycobacterium w. J. Ind. Med. Assoc. 100 (2002) 578-579
12. Cayabyab M.J., Hovav A.H., Hsu T., Krivulka G.R., Lifton M.A., Gorgone D.A., Fennelly G.J., Haynes B.F., Jacobs Jr. W.R., and Letvin M.L. Generation of CD8+T cell responses by a recombinant non-pathogenic Mycobacterium smegmatis vaccine vector expressing Human Immunodeficinecy Virus Type 1 Env. J. Virol. 80 (2006) 1645-1652
13. Roach T.I., Barton C.H., Chatterjee D., and Blackwell J.M. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE and tumor necrosis factor-α. J. Immunol. 150 (1993) 1886-1896
14. Roach T.I., Barton C.H., Chatterjee D., Liew F.Y., and Blackwell J.M. Opposing effects of interferon-γ on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology 85 (1995) 106-113
15. Majumder N., Dey R., Mathur R.K., Datta S., Maitra M., Ghosh S., Saha B., and Majumdar S. An unusual pro-inflammatory role of interleukin-10 induced by arabinosylated lipoarabinomannan in murine peritoneal macrophages. Glycoconj. J. 23 (2006) 675-686
16. Havlir D.V., Wallis R.S., Boom W.H., Daniel T.M., Chervenak K., and Ellner J.J. Human Immune responses to Mycobacterium tuberculosis antigens. Infect. Immun. 59 (1991) 665-670
17. Hamasur B., Kallenius G., and Svenson S.B. A new rapid and simple method for large-scale purification of mycobacterial Lipoarabinomannan. FEMS Immunol. Med. Microbiol. 24 (1999) 11-17
18. Scanga C.A., Mohan V.P., Tanaka K., Alland D., Flynn J.L., and Chan J. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect. Immun. 69 (2001) 7711-7717
19. Bean A.G.D., Roach D.R., Briscoe H., France M.P., Korner H., Sedgwick J.D., and Britton W.J. Structural deficiencies in granuloma formation in TNF gene targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by Lymphotoxin. J. Immunol. 162 (1999) 3504-3511
20. Pancholi P., Vinayak V.K., and Khuller G.K. Immunogenicity of ribonucleic acid protein fraction of Mycocaterium tuberculosis encapsulated in liposomes. J. Med. Microbiol. 29 (1989) 131-133
21. Zhang C., Wang S., Lasbury M.E., Tschang D., Liao C., Durant P.J., and Lee C. Toll Like Receptor 2 mediates alveolar macrophage response to Pneumocystis murina. Infect. Immun. 74 (2006) 1857-1864
22. Basu R., Bhaumik S., Basu J.M., Naskar K., De T., and Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both Pentavalent Antimonial-sensitive and resistant strains of Leishmania donovani that correlates with Inducible Nitric Oxide Synthase activity and IL-4 generation: evidence for Mixed Th1 and Th2 like responses in Visceral Leishmaniasis. J. Immunol. 174 (2005) 7160-7171
23. Chomezynaski P., and Sacchi N. A single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
24. Leite F., O'Brien S., Sylte M.J., Page T., Atapattu D., and Czuprynski C.J. Inflammatory cytokines enhance the interaction of Mannheimia hemolytica leukotoxin with bovine peripheral blood neutrophils in vitro. Infect. Immun. 70 (2002) 4336-4343
25. Kitatani K., Idkowiak-Baldys J., and Hannun Y.A. Mechanism of inhibition of sequestration of protein kinase C α/βII by ceramide: roles of ceramide activated protein phosphatases and phosphorylation/dephosphorylation of protein kinase C α/βII on threonine 638/641. J. Biol. Chem. 282 (2007) 20647-20656
26. Ghosh S., Pal S., Das S., Dasgupta S.K., and Majumdar S. Lipoarabinomannan induced cytotoxic effects in human mononuclear cells. FEMS Immunol. Med. Microbiol. 21 (1998) 181-188
27. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., Schreiber R., Mak T.W., and Bloom B.R. Tumor necrosis Factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2 (1995) 561-572
28. Ladel C.H., Daugelat S., and Kaufmann S.H.E. Immune response to Mycobacterium bovis bacilli Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knockout mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25 (1995) 377-384
29. Wieland C.W., Knapp S., Florquin S., de Vos A.F., Takeda K., Akira S., Golenbock D.T., Verbon A., and van der Poll T. Non mannose capped lipoarabinomannan induces lung inflammation via Toll like receptor-2. Am. J. Resp. Crit. Care Med. 170 (2004) 1367-1374
30. Yoshikai Y. Immunological protection against Mycobacterium tuberculosis infection. Crit. Rev. Immunol. 26 (2006) 515-526